跳到主要內容

Whitmore Bradford T 的 Form 4 申報

Ultralife Corp(ULBI),2022/12/16 申報

申報編號
0000933430-22-000012
申報時間
2022/12/16
交易日
2022/12/14-12/16
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 3 筆非衍生性交易。公開市場買進合計 $15.2 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Whitmore Bradford TCIK 0000933430董事、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/12/14Common StockP買進取得+25,694$4.01F1+$103,032.94969,343直接
2022/12/15Common StockP買進取得+5,138$3.94F2+$20,243.72974,481直接
2022/12/16Common StockP買進取得+7,200$3.98F3+$28,656981,681直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.925 to $4.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.

表 I 有 1 筆交易的價格引用這則附註。

F2

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.95. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.

表 I 有 1 筆交易的價格引用這則附註。

F3

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.94 to $4.00. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)